Investor FAQs
General/Corporate
OpGen operates virtually.
OpGen is incorporated in Delaware.
OpGen priced its initial public offering on May 4, 2015, offering 2,850,000 units, with each unit consisting of one share of common stock and a warrant to purchase one share of common stock, at a combined price to the public of $6.00 per unit.
OpGen’s fiscal year ends on December 31.
OpGen’s common stock (OPGN) and warrants (OPGNW) are suspended from trading on the NASDAQ Capital Market. OpGen’s securities are on the expert market.
Transfer Agent
The Company does not pay dividends and has no plans to do so for the foreseeable future.
Dividends
Pacific Stock Transfer Company
6725 Via Austi Parkway, Suite 300
Las Vegas, Nevada 89119
Phone: 702-361-3033
Toll Free: 1-800-785-7782
Fax: 702-433-1979
info@pacificstocktransfer.com
Contact the transfer agent.
Contact the transfer agent.
OpGen does not have a direct stock purchase plan.
Auditor/Legal
Mario A. Beckles, CPA
400 Columbia Drive, Suite 101
West Palm Beach, FL 33409
Ballard Spahr LLP
1735 Market Street
Philadelphia, PA 19103
Company Inquiries
Please access the news release section of the company’s website.
Please see the SEC filings link on the Investor Relations section of the Company’s website, or visit www.sec.gov
Please see the Corporate Governance link on the Investor Relations section of the Company’s website.
Please contact InvestorRelations@OpGen.com
Please check Upcoming Events for most current announcements.